Company Filing History:
Years Active: 2012-2020
Title: Jiewen Zhu: Innovator in Cancer Treatment
Introduction
Jiewen Zhu is a prominent inventor based in Irvine, CA, known for his significant contributions to cancer treatment through innovative research. With a total of six patents to his name, Zhu has made strides in developing novel therapeutic compounds aimed at combating cancer.
Latest Patents
Among his latest patents, Zhu has focused on RAD51 inhibitors and their uses. These inventions include novel RAD51 inhibitors that may be useful in preventing or treating cancer in subjects in need. The methods outlined in his patents involve administering a therapeutically effective amount of these compounds to patients, showcasing his commitment to advancing cancer therapies.
Career Highlights
Zhu's career is marked by his association with the University of California, where he conducts his research and development. His work has garnered attention for its potential impact on cancer treatment, positioning him as a key figure in the field of medical innovation.
Collaborations
Zhu collaborates with esteemed colleagues such as Wen-Hwa Lee and Phang-Lang Chen, further enhancing the scope and depth of his research endeavors.
Conclusion
Jiewen Zhu's innovative work in developing RAD51 inhibitors represents a significant advancement in cancer treatment. His contributions to the field highlight the importance of research and collaboration in the fight against cancer.